Prostate Cancer
The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate.
September 6, 2024
Comparison of Pathologist and Artificial Intelligence-based Grading for Prediction of Metastatic Outcomes After Radical Prostatectomy.
September 6, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions.
September 5, 2024
A Multi-Institutional Study of MR/US Fusion Guided Nanoparticle Directed Focal Therapy for Prostate Ablation.
September 5, 2024
Talazoparib for the treatment of prostate cancer.
September 5, 2024
PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer.
September 5, 2024
The Proteogenomics of Prostate Cancer Radioresistance.
September 5, 2024
Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysis.
September 4, 2024
Androgen production, uptake, and conversion (APUC) genes define prostate cancer patients with distinct clinical outcomes.
September 4, 2024
Statin concentration in prostatic tissue is subtype- and dose-dependent.
September 4, 2024